Tilray Brands, Inc. (TLRY)
Market Cap | 1.68B |
Revenue (ttm) | 627.12M |
Net Income (ttm) | -1.45B |
Shares Out | 703.26M |
EPS (ttm) | -2.35 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 15,597,650 |
Open | 2.39 |
Previous Close | 2.35 |
Day's Range | 2.33 - 2.42 |
52-Week Range | 1.50 - 5.12 |
Beta | 2.52 |
Analysts | Hold |
Price Target | 3.48 (+45.61%) |
Earnings Date | Oct 4, 2023 |
About TLRY
Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-ba... [Read more]
Full Company ProfileFinancial Performance
In 2023, Tilray's revenue was $627.12 million, a decrease of -0.20% compared to the previous year's $628.37 million. Losses were -$1.45 billion, 204.7% more than in 2022.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for TLRY stock is "Hold." The 12-month stock price forecast is $3.48, which is an increase of 45.61% from the latest price.
News

‘Potently Canadian' Cannabis Brand, CANACA, Launches ‘Let ‘Er Rip' Campaign
TORONTO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced th...

Cannabis stock gains fade in volatile trading on US Senate bill hopes
Shares of marijuana companies gave back early gains on Wednesday after jumping following a U.S. Senate committee voted to advance a bill that would give legal cannabis-related companies a boost by all...

Cannabis stock rise as Senate committee OKs cannabis banking bill
Cannabis stocks moved up Wednesday after the U.S. Senate Committee on Banking, Housing and Urban Affairs approved the Secure and Fair Enforcement Regulation Banking Act, now known as the SAFER Banking...

Navigating the Highs: Canadian Cannabis Stocks in September 2023
The Canadian cannabis industry and top marijuana stocks continue to blaze a trail of opportunity for investors in September 2023, with several top Canadian cannabis companies gaining substantial tract...

Tilray Brands, Inc. to Announce First Quarter 2024 Financial Results on October 4, 2023
NEW YORK and LEAMINGTON, Ontario, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer package...

Tilray's Best-Selling Beers Make Landfall at Atlantis, Bahamas
Montauk Brewing and SweetWater Brewing's Beers Now Available at the Resort's Top Dining Locations Montauk Brewing and SweetWater Brewing's Beers Now Available at the Resort's Top Dining Locations
Investing in Weed
Todd Harrison, founding partner and CIO at CB1 Capital Management, discusses marijuana investing and outlook for the industry on Bloomberg Markets. This interview aired 09/15/23

Cannabis banking bill looks poised to get Senate committee's OK on Sept. 27
The Senate Banking Committee looks set to vote in a week and a half to advance a much-anticipated bill that aims to make it easier for the financial industry to work with cannabis companies.

Montauk Brewing Expands Distribution Beyond the Northeast
Montauk's Easy-Drinking and Best-Selling Craft Beers Are Now Available at Major Retailers, Restaurants and Bars Across Georgia Montauk's Easy-Drinking and Best-Selling Craft Beers Are Now Available at...

3 Marijuana Stocks To Watch As The Cannabis Industry Continues To Grow
Marijuana stocks are the investment of the future for many reasons. For instance, the legal cannabis industry is still new and developing quickly. It was not long ago when the talks about legal cannab...

Cannabis Stocks: Green Gold Rush or Risk Off?
The world of investing and trading is abuzz with excitement as one sector theme has recently emerged as a blazing hot topic of discussion: cannabis stocks.

Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging
Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cann...

Tilray Expands Market Leading Cannabis Portfolio With Launch of New Redecan Products Across Canada
Best-Selling Redecan Brand Gets a Boost with New Limited-Edition Cannabis Flower Genetics and Product Lineup Best-Selling Redecan Brand Gets a Boost with New Limited-Edition Cannabis Flower Genetics a...

Green Investments: Top Canadian Marijuana Stocks for September 2023
We're glad you're here to learn about this week's top marijuana stocks, poised to see significant increases in September 2023. As the cannabis industry evolves, savvy investors seek opportunities whil...

Will This New Development Mean A Big Rally In Cannabis Stocks?
Curaleaf Holdings Inc. OTCMKTS: CURLF, Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Human...

Cannabis stocks are still a buy despite recent double-digit gains
Cannabis stocks have come roaring back on recent news of major decriminalization progress at the federal level. The big question now for anyone who owns marijuana stocks or is considering the sector: ...

Cannabis Stocks Surge After HHS Recommends Classifying Marijuana As Lower-Risk Drug
The recommendation is part of a larger marijuana reform plan announced by the Biden Administration last year.

U.S. health officials want to loosen marijuana restrictions. Here's what it means
If marijuana is downgraded to a Schedule III drug, it could be a huge boost to a struggling industry.

Why are cannabis stocks trading significantly up on Thursday?
Cannabis stocks are celebrating this morning after the U.S. Department of Health and Human Services recommended in a letter to the Drug Enforcement Administration that Marijuana be reclassified as a S...

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q...

Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug
Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.

Pot stocks jump as federal agency reportedly seeks to downgrade cannabis from the hard-drug category
The Drug Enforcement Agency received an official recommendation to downgrade marijuana. Currently, pot is classified as a Schedule I drug, on par with heroin.

HHS calls for easing restrictions on marijuana, sending cannabis stocks higher
That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

U.S. Dept. of Health and Human Services recommends re-scheduling cannabis, as stocks in the sector rally
The U.S. Department of Health and Human Services is recommending to the U.S. Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under U.S. law ...

RIFF Cannabis Launches New Diamond Infused Pre-Rolls and Blunts
The New Hand-Crafted RIFF Diamond Infused Pre-rolls and Blunts Are Now Available in Ontario PURE ‘DIAMONDS COLLECTION' IS ‘A CUT ABOVE' TORONTO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc...